Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q3 2024 · 10-Q
Revenue$8.12M$8.12M+41.0% vs Q3 2023 Net Income-$4.97M-$4.97MN/M vs Q3 2023 EPS Diluted-$0.18-$0.18N/M vs Q3 2023 Gross Profit$4,847,000+48.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,199,000N/M Free Cash Flowderived-$1,211,000N/M Margins · derivedGross margin59.7%+2.9 pt vs Q3 2023
Operating margin-63.5%+21.5 pt vs Q3 2023
Net margin-61.2%+22.2 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 7, 2024 · 38 d after period end